Dexmethylphenidate Extended-Release

Dexmethylphenidate extended-release is a prescription drug that is licensed to treat attention deficit hyperactivity disorder (ADHD). While the medicine is a stimulant, it produces a calming effect. In previous studies, dexmethylphenidate extended-release was shown to be effective at treating symptoms of ADHD in both children and adults. Headaches, throat pain, and dry mouth are a few of the common side effects with this medication.

Dexmethylphenidate Extended-Release Info

What Is Dexmethylphenidate Extended-Release?

Dexmethylphenidate extended-release (Focalin XR^®) is a prescription medication that is used for the treatment of attention deficit hyperactivity disorder (ADHD). Dexmethylphenidate extended-release capsules are specially designed to release half of the medication immediately, and to release the second half of the medication after approximately four hours. As a result, dexmethylphenidate extended-release can be taken just once a day.

Because dexmethylphenidate extended-release is a stimulant and is commonly abused, there are special rules for prescribing the medication (see Focalin XR: A Controlled Substance).

(Click What Is Dexmethylphenidate Extended-Release Used For? for more information on uses of dexmethylphenidate extended-release, including possible off-label uses.)

Who Makes Dexmethylphenidate Extended-Release?

Dexmethylphenidate extended-release is manufactured by Novartis Pharmaceuticals.

(Dexmethylphenidate Extended-Release Continued: Page 2)